GlassScriptPhysician profile
Tomoyo Park
NPI 1851902571
$3,111.21
in general payments reported to CMS, 2019-2025
11 companies · $658 in 2025
The $658 reported for 2025 was more than what 76% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $197 · 2022: $646 · 2023: $1,059 · 2024: $551 · 2025: $658.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,268.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,267.87 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abiomed | $1,977.70 | 2021-2025 | Impella |
| Edwards Lifesciences Corporation | $247.76 | 2021-2023 | Hemosphere |
| Inari Medical, INC. | $185.12 | 2023 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $169.63 | 2021-2023 | Lifevest |
| Getinge USA Sales, LLC | $141.66 | 2022-2023 | Vasoview Hemopro 2 |
| Fresenius Kabi USA, LLC | $117.00 | 2023 | Smoflipid |
| La Jolla Pharmaceutical Company | $116.44 | 2023 | Giapreza |
| Atricure, INC. | $61.34 | 2021-2022 | |
| Davol INC. | $50.56 | 2022 | |
| Clearflow INC. | $22.00 | 2022 | |
| Stryker Corporation | $22.00 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Tomoyo Park listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.